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In contrast, a Iowermotiality rate waa associated with cardiac surgery for the
other shock pts (36% vs 71% p < 0.0001).
In conclusion, VSR/fvlRcaused shock in 14%of pts registered with shock
and AMI. VSWMR pts were less likely to have anterior Ml and more likely
to have posterior Ml, with shock onset at a significantly longer time peat Ml.
Pts. with mechanical complication (VSFVMR)have the worst prognosis of
all shock pts due to AMI. To impact on the very high mortality once shock
has occurred, early detection and treatment of VSFVMRare required prior to
shock onset.
m106198 Charactariatics and Outcome of Patients with
Cardiogenic Shock Due to Right Ventricular
Dvafunction: A Re~ort from the SHOCK Trial
R&gistry
J.D. Bier, J.S. Cohen, L. Sleeper, G.N. Levine, R. Davidoff, J.D. Talley,
E. Bates, T. LeJemtel, J. Hochman, A.K. Jacobs for the SHOCK
Investigators. Boston Medical Centec Boston, MA, USA, St.
Luke’.s/RooeeveltHospital Centec New York, NY USA
To evaluate the clinical characteristics and outcome of ptswith acute myccer-
dial infarction (AMI) and cerdiogenic shock (CS) due to right ventricular (RV)
dysfunction, we queried the SHOCK trial registry, a prospectively collected
database which includes all pts with suspc@edCS due to AMI not enrolled
in the randomized SHOCK trial. RV CS was defined on clinical grounds.
Twenty-one pt.$with predominant RV CS were compared with 105 pts with
predominant LV CS (Cls 2.2 Umin). Clinical characteristics are shown:
PredominantRV PredominantLV p-value
Amsfvrs) 65.9 + 10.1 69.3 + 9.8 0.16
.“– ., ,Meie(“A) 57.1 53.3 0.s1
AnteriorMl (oh) 15 56.4 0.001
Prior Ml (%) 20.0 39.6 0.13
PCWP (mmHg) 18&5 25& 9 0.009
Cl. (Umin) 1.7 l 0.4 1,6 + 0.4 0.65
LyticRate (“A) 42.9 43,6 1.00
IAB (%) 38.1 64.8 0.03
In-hospital mortality was high in both groups (RV 47.6%, LV 62.9Y0, p =
0.23). Interestingly, pts with RV CS were treatad with PTCA lees frequently
than pts with LV CS (19.1 vs 41.9%, p = 0.053). Therefore, despite having
fewer anterior Mls, a trend towards fewer prior Mlsand Iowerfilling pressures
than pts with LV CS, pts with RV CS also have a high in-hoapital motility.
The infrequent use of PTCA in this group may bean important observation
and should be the subject of future study.
m106199 New Device Intervention in Cardiogenic Shock
B.D. Caries, J. Lindsay, Jr., E.E. Pinnow, A.D. Pichard. The Washington
Hospital Centec Washington, DC, USA
Few data are available regarding percutaneous transluminal coronary revas-
cularization (PTCR) in patients with cardicgenic shock (CS).The efficacyand
feasibility of new device (ND) [atherectomy, laser, and stent] intervention in
this critically ill population has not been explored. We raviewed our experi-
ence of PTCR in CS patients, and identified 53 patients (age 84 A 12 ye-are,
29 [55%] men), treated in our laboratory from Januaty 1994 through April
1996. CS was defined as 2 or more of the following: clinical hypoperfusion,
dependence on vasopressor support, SBP <90 mmHg,”PCWP z 16 mmHg,
Cls 2.1 Umirt/BSA.
Clinical, angiographic and outcome variables were collected via a ret-
rospective chart review. Sixteen (30°Z.)patients died despite interventional
therapy. Therapy was categorized as balloon angioplasty alone (POBA) in
31; or new device (ND) in 21. One patient who died after his lesion could not
be crossed was excluded from the analysis of device use and mortality.
Mortality was significantly lower (p = 0.03) in patients with ND (9.5%)
compared to POBA (41.9Yo). An analysis of stent vs. no stent revealad a
significant difference in mortality, 6.3Y0vs. 37.8% (p = 0.04), in favor of
stent use. Thifly-nine (75%) patients had CS associated with acute infarction
(AMI), 12 othara had unstable angina. All deaths occurred in the 39 patients
who presented with AMI. In this subgroup, both ND and stent use were
associated with a lower mortality (p= 0.06/0.08).
Mortality(All patients) Mortality(AMI patients)
ND: 2/21 [9.5%) D = 0.03 ND: 2/13 (15.4”/0)P = 0.06
POBA: 13)31 (41”.9%) POBA: 1426 (50”;0)
Stent: 1/15 (6.3%) p = 0.04 Stent: 1/10 (10%) p= 0.06
No stent: 14/37 (37.6%) No stent: 14/29 (46.3”A)
I lf361-~ EndOtoxemiaAltef’a SplanchnicCapacitence
M.R. Ujhelyi, A.P. Winecoff, S. Raibon, J, Corley, S. Li, V.B. Robinson,
A. Illebek, T. Tonnessen, G. Burke, D.L. Rutlen. Univof GA, Augusta VAMC
and Med Coil of GA, Augusta GA, USA, Univ of Oslo, Norway
It is known that unresuscitated endotoxemic (LPS) shock reduces cardiac
output. Since the splanchnic circulation constitutes a major portion of the
total cqktcitence vasculature, it is ~ssible that an increase in splanchnic
blood volume leads to a decrease in venous return and subsequently car-
diac output, However, it is unknown if LPS affects splanchnic capacitance
vessels. We assessed the effects of Ecoli LPS (10 @kg over 5 minutes) on
individual (liver, splenic, mesenteric) and total splanchnic blood volume in 5
unresuscitated farm swine. Splanchnic blood volume was measured using
Tcwmlabeled erythrocytes and radionuclide imaging. Mean arterial pressure
(MAP) and splanchnic volumes were recorded every 5 minutes during a
basal period and after the start of LPS infusion (Orein).
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The figure shows MAP, liver and splenic volume as a percent of baseline
before (-5to Omin) andafter LPS (5-30 rein). LPSdecreaaed splenic volume
by 45% and MAP by 60% while liver volume increased by 40% (p < 0.01).
Mesenteric and total splanchnic volume were unchanged. It is likely that the
Iackof change in total splanchnic volume was due tothe counteracting affects
of changes in splenic and hepatic volume. Since total splanchnic volume was
unchanged, the reduction in cardiac output in unresuscitated LPS shock is
not due to pooling of blood volume in the splanchnic capacitance circulation.
-[ M@ti@eTriggering Mechaniafn50fVa50vagai
Syncope: A Patient-Controlled Study
A.M. Fanton, P.A. Low, C. Lohse, S.C. Hammill, W.K. Shen. Mayo C/inic,
Rocheste< MN, USA
Recent studies suggest multiple reflexogenic mechanisms may trigger a
vasovagal respmse in different patient populations. We hypothesized that
the triggering mechanisms may vary even in the same patients. Reexamined
hemodynamic changes of 6 patients (F/M= 4/2; mean age= 45 yr) who had
vasovagal syncope induced by txih 45 min head up tilt alone and tilt + Iso
infusion (0.05 pg/k@min). The protocol order waa randomized. Impedance
cardiography and plethysmography was used to collect data. Hemodynamics
during both protocols (Tilt * Iso) were compared in each patient. Mean
responseswhile supine, and at peak responsejust before onset of symptoms
(reflecting triggering mechanisms of incipient syncope) are shown:
Hemodynsmica Mean Change, Tilt:
Supine Peak Response before Sx.
lsO– 1s0+ 0 lsO- 1s0+ D
HR, bpm 63 96 <0,0005 29°h 844A <0.05
SBP, mmHg 136 131 n.s, 1“/. –120/0 n.s,
DBP, mmHg 77 65 <0,05 0“/. –13°A n.s.
CO, Umin 6.3 10.6 <0.05 –117. 103’% <0.05
Sv, cc 103 114 n.a, –32”h 5% <0,05
EDV, cc 178 206 ns, –15”/0 3% <0.005
TPR, dyn-s/cm3 1286 796 <0.005 13”/0 –54”/0 <0.005
Observations: 1) While supine, Iso increased HR and CO, and decreased
DBP and TPR. 2) During tilt alone, EDV decreased (reflecting preload), and
TPR increased (afterload) prior to onset of symptoms. 3) Addition of Iso to
tilt significantly increased HR, SV, and CO (cardiomotor tone) and reversed
tilt-induced changes in EDV and TPR.
Conclusions: 1)Triggering mechanisms of vasovagal syncope can differ
in the same patient. 2) These observations may explain why response to
therapy targeting triggering mechanisms may be less than satisfactory.
Conclusion: ND can be safely used in CS patients. Coronary stenting may
be associated with a lower mortality.
